New minimally invasive device may soon replace endoscopy for Barrett's esophagus diagnosis
the ONA take:
According to a new study published in the journal PLOS Medicine, reseearchers from the University of Cambridge MRC Cancer Unit in Cambridge, United Kingdom, have found that a new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus rather than be referred for endoscopy for diagnosis.
For the study, researchers sought to evaluate the accuracy, safety, and acceptability of the test compared with endoscopy for the diagnosis of Barrett's esophagus, a disorder characterized by an abnormal change in the cells of the lower part of the esophagus that is a risk factor for the development of esophageal cancer.
Researchers enrolled 1,110 patients from various hospitals in the United Kingdom who were referred for a diagnostic endoscopy for symptoms of dyspepsia and reflux symptoms.
Results showed that the new minimally invasive test accurately diagnosed 79.7% of the 647 patients with endoscopically diagnosed Barrett's esophagus, and correctly identified 92.4% of 463 of those unaffected by Barrett's esophagus as not having Barrett's esophagus.
Researchers found that the test had an 87.2% sensitivity when patients had a circumferential Barrett's segments over 3cm. Most patients were able to swallow the device without issues and no adverse events were observed.
A new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|